Latest Listicles

Companion diagnostic (CDx) tests are co-developed with their “companion” therapy and aim to aid medical decision-making by revealing which patients are (and are not) likely to respond well to a particular treatment. In this list, we discuss the main drivers of growth in CDx research.

There has been an acceleration in our understanding of how cancer evades the immune system, and an explosion in new therapeutics that re-configure the immune system to mount a powerful anticancer response. Download this list to learn more.

In this list, we provide insight into the most recent research exploring the exciting, modern and futuristic application of synthetic DNA.

Download this article to learn how advanced throughput flow cytometry overcomes these challenges to drive forward innovation in the immuno-oncology field.

The Evolution of Proteomics featured a series of interviews with experts in the field of proteomics research. We asked each of the experts what, in their opinion, are the greatest challenges currently existing in proteomics, and how can we look to overcome them?

This list highlights ten major milestones within the field of cancer research since the year 2000.

Download this list to learn about organoid formation and characterization, plus the applications of organoid cultures in cancer research.

Download this list to discover how advanced flow cytometry platforms have simplified workflows and sample prep to revolutionize screening, lead development, bioprocessing and clinical trials.

There is no one-size-fits-all method for validating antibodies. This list details validation approaches that are common to all applications, and highlights things to consider for specific applications, such as detecting post-translational modifications.

Combating AMR is going to take coordinated action of different approaches, such as improved public education and national action plans, greater surveillance, improved diagnostics, and the ability to harness advances in genomics and big data.